Beta-CIT-SPECT and Neurophysiology in Depression

L

Ludwig Maximilian University of Munich

Status and phase

Completed
Phase 4

Conditions

Depression

Treatments

Procedure: β-CIT-SPECT, Neurophysiology

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00145132
ESCIT-SPECT-Pogarell
EK287/98

Details and patient eligibility

About

Aim of this project is to investigate the effects of escitalopram on monoamine transporter (SERT, DAT) availabilities as assessed by b-CIT and SPECT, and on neurophysiological parameters such as the loudness dependence of auditory evoked potentials (LDAEP) in patients with depression.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Psychiatric in or outpatients with acute depressive episode
  • Indication for pharmacological treatment

Exclusion criteria

  • Acute suicidality
  • Neurological or severe somatic disorders
  • Occupational exposition to radiation >15 mSv per year
  • Women during pregnancy or lactation

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems